Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul;4(4):252-6.
doi: 10.6004/jadpro.2013.4.4.5.

Two Patients With Brain Tumors Who Received Bevacizumab and Radiotherapy: Optic Neuropathy and Quality-of-Life Issues

D Beverly Fu  1 , Daniela Alexandru  1 , Dana M Curticiu  1 , Yao Fu  1 , Daniela A Bota  1
Affiliations
Review

Two Patients With Brain Tumors Who Received Bevacizumab and Radiotherapy: Optic Neuropathy and Quality-of-Life Issues

D Beverly Fu et al. J Adv Pract Oncol. 2013 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 1. Brain MRIs (for Mr. R. and Mr. L.) showing the areas receiving radiation (radiation planning maps).
Figure 2
Figure 2
Figure 2. Brain areas (for Mr. R. and Mr. L.) selected to receive an additional amount of radiation due to tumor proximity (IMRT boost).
Table 1
Table 1
Table 1. Clinical Information for Cases 1 and 2
Table 1
Table 1
Table 1. Quality-of-Life Issues Experienced in Cases 1 and 2
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Chamberlain M. C., Raizer J., Schiff D., Sherman J. H. Optic neuropathy in patients with glioblastoma receiving bevacizumab. Neurology. 2010;75:289–290. - PubMed
    1. Desai M., Pratt L. A., Lentzner H., Robinson K. N. Trends in vision and hearing among older Americans. Aging Trends. 2001;March (2):1–8. - PubMed
    1. Evans Jennifer R, Fletcher Astrid E, Wormald Richard P L. Depression and anxiety in visually impaired older people. Ophthalmology. 2007;114:283–288. - PubMed
    1. Finger Paul T. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy. American journal of ophthalmology. 2007;143:335–338. - PubMed
    1. Gilbert M. R., Dignam J., Won M., Blumenthal D. T., Vogelbaum M. A., Aldape K. D., Mehta M. P. RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM) [Abstract 1]. Journal of Clinical Oncology. 2013;31(suppl)

LinkOut - more resources